IFNG and colon carcinoma: Indeed, it has been shown that metastatic human colon carcinoma cells are more resistant to TARL than the primary colon carcinoma cells [35] and we have observed that metastatic colon carcinoma cells become resistance to IFN-γ sensitization (Fig. 1).